Maspin expression in oral squamous cell carcinoma

Journal of Craniofacial Surgery

Volumn 18, Issue 5, 2007, Pages 1039-1043

  Iezzi, Giovanna ^a   Piattelli, Adriano ^a   Rubini, Corrado ^b   Goteri, Gaia ^b   Artese, Luciano ^a   Perrotti, Vittoria ^a   Carinci, Francesco ^c  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

Author keywords

Immunohistochemistry; Marker; Maspin 2; Oral carcinoma

Indexed keywords

MASPIN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPH NODE METASTASIS; MALE; MOUTH CANCER; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION; TUMOR GROWTH;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM PROTEINS; SERPINS; SURVIVAL ANALYSIS;

EID: 34948848591     PISSN: 10492275     EISSN: None     Source Type: Journal    
DOI: 10.1097/scs.0b013e31814b2a36     Document Type: Article

References (32)

1. Nakashima T, Yasumatsu R, Kuratomi Y, et al. Role of squamous cell carcinoma antigen 1 expression in the invasive potential of head and neck squamous cell carcinoma. Head Neck 2006;28:24-30
2. Nakagawa M, Katamura H, Adachi M, et al. Maspin expression and its clinical significance in non-small cell lung cancer. Ann Surg Oncol 2006;13:1517-1523
3. De Lima Navarro R, Trierveiler Martins M, Cavalcanti de Araujo V. Maspin expression in normal and neoplastic salivary gland. J Oral Pathol Med 2004;33:435-440
4. Romani AA, Soliani P, Desenani I, et al. The associate expression of maspin and Bax proteins as a potential prognostic factor in intrahepatic cholangiocarcinoma. BMC Cancer 2006;6:255
5. Zhang M, Volpert O, Shi YH, et al. Maspin is an angiogenesis inhibitor. Nat Med 2000;6:196-199
6. Vereecken P, Reynaert S, Lalmand MC, et al. Decreased immunoreactive expression in intermediate thickness and thick primary melanoma lesions. J Int Med Res 2006;34:52-57
7. Xu C, Quddus MR, Sung CJ, et al. Maspin expression in CIN 3, microinvasive squamous cell carcinoma, and invasive squamous cell carcinoma of the uterine cervix. Mod Pathol 2005;18:1102-1106
8. Rose SL, Fitzgerald MP, White NO, et al. Epigenetic regulation of maspin expression in human ovarian carcinoma cells. Gynecol Oncol 2006;102:319-324
9. Song SY, Lee SK, Kim DH, et al. Expression of maspin in colon cancers. Its relationship with p53 expression and microvessel density. Dig Dis Sci 2002;47:1831-1835
10. Maass N, Teffner M, Rosel F, et al. Decline in the expression of the serine proteinase inhibitor maspin is associated with tumour progression in ductal carcinomas of the breast. J Pathol 2001;195:321-326
11. Schaefer JS, Zhang M. Role of maspin in tumor metastasis and angiogenesis. Curr Mol Med 2003;3:653-658
12. Yin S, Li X, Meng Y, et al. Tumor-suppressive maspin regulates cell response to oxidative stress by direct interaction with glutathione S-transferase. J Biol Chem 2005;280:34985-34996
13. Cella N, Contreras A, Latha K, et al. Maspin is physically associated with beta1 integrin regulating cell adhesion in mammary epithelial cells. FASEB J 2006;20:1510-1512
14. Chen EI, Yates JP. Maspin and tumor metastasis. IUBMB Life 2006;58:25-29
15. Umekita Y, Yoshida H. Expression of maspin is up-regulated during the progression of mammary ductal carcinoma. Histopathology 2003;42:541-545
16. Kim DH, Yoon DS, Dooley WC, et al. Association of maspin expression with the high histological grade and lymphocyterich stroma in early-stage breast cancer. Histopathology 2003;42:37-42
17. Boltze C. Loss of maspin is a helpful prognosticator in colorectal cancer: a tissue microarray analysis. Pathol Res Pract 2005;200:783-790
18. Ito R, Nakayama H, Yoshida K, et al. Loss of maspin expression is associated with development and progression of gastric carcinoma with p53 abnormality. Oncol Rep 2004;12:985-990
19. Friedrich MG, Toma MI, Petri S, et al. Expression of maspin in non-muscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis. Eur Urol 2004;45:737-743
20. Yasumatsu R, Nakashima T, Hirakawa N, et al. Maspin expression in stage I and II oral tongue squamous cell carcinoma. Head Neck 2001;23:962-966
21. Xia W, Lau K, Hu MC, et al. High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma. Oncogene 2000;19:398-403
22. Secord AA, Lee PS, Darcy KM, et al. Maspin expression in epithelial variant cancer and associations with poor prognosis: a gynecologic oncology group study. Gynecol Oncol 2006;101:390-397
23. Katakura H, Takenaka K, Nakagawa M, et al. Maspin gene expression is a significant prognostic factor in resected non-small cell lung cancer (NSCLC). Lung Cancer 2006;51:323-328
24. Blandamura S, Giacomelli L, Leo G, et al. Nuclear maspin detection in renal cell tumours: possible diagnostic role and correlation with p53 status. Histopathology 2006;49:274-282
25. Lonardo F, Li X, Siddiq F, et al. Maspin nuclear localization is linked to favorable morphological features in pulmonary adenocarcinoma. Lung Cancer 2006;51:31-39
26. Solomon LA, Munkarah AR, Schimp VL, et al. Maspin expression and localization impact on angiogenesis and prognosis in ovarian cancer. Gynecol Oncol 2006;101:385-389
27. Murai S, Maesawa C, Masuda T, et al. Aberrant maspin expression in human endometrial cancer. Cancer Sci 2006;97:883-886
28. Martins MT, Altemani A, Freitas L, et al. Maspin expression in carcinoma ex pleomorphic adenoma. J Clin Pathol 2005;58:1311-1314
29. Machtens S, Serth J, Bokemeyer C, et al. Expression of the p53 and maspin protein in primary prostate cancer: correlation with clinical features. Int J Cancer 2001;95:337-342
30. Maesawa C, Ogasawara S, Yashima-Abo C, et al. Aberrant maspin expression in gallbladder epitheliumis associated with intestinal metaplasia in patients with cholelithiasis. J Clin Pathol 2006;59:328-330
31. Marioni G, Blandamura S, Giacomelli L, et al. Nuclear expression of maspin is associated with a lower recurrence rate and a longer disease-free interval after surgery for squamous carcinoma of the larynx. Histopathology 2005;46:558-576
32. Cao D, Wilentz RE, Abbruzzese JL, et al. Aberrant expression of maspin in idiopathic inflammatory bowel disease is associated with disease activity and neoplastic transformation. Int J Gastrointest Cancer 2005;36:39-46